You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Details for New Drug Application (NDA): 009829


✉ Email this page to a colleague

« Back to Dashboard


NDA 009829 describes MESTINON, which is a drug marketed by Bausch and is included in four NDAs. It is available from two suppliers. Additional details are available on the MESTINON profile page.

The generic ingredient in MESTINON is pyridostigmine bromide. There are eleven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 009829
Tradename:MESTINON
Applicant:Bausch
Ingredient:pyridostigmine bromide
Patents:0
Pharmacology for NDA: 009829
Mechanism of ActionCholinesterase Inhibitors
Medical Subject Heading (MeSH) Categories for 009829
Suppliers and Packaging for NDA: 009829
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESTINON pyridostigmine bromide TABLET;ORAL 009829 NDA Bausch Health US, LLC 0187-3010 0187-3010-30 100 TABLET in 1 BOTTLE (0187-3010-30)
MESTINON pyridostigmine bromide TABLET;ORAL 009829 NDA AUTHORIZED GENERIC Oceanside Pharmaceuticals 68682-302 68682-302-10 100 TABLET in 1 BOTTLE (68682-302-10)

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.